| Name | Title | Contact Details |
|---|
Versartis, Inc. (NASDAQ: VSAR) is an endocrine-focused biopharmaceutical company developing novel, long-acting medicines to transform treatment for patients with endocrine disorders. The company is led by a management team with rich experience and expertise discovering, developing and commercializing innovative therapeutics for the life sciences industry. Versartis` mission is to develop, manufacture and commercialize novel therapeutics to improve and transform treatment for patients with orphan endocrine disorders. Versartis is well-positioned to deliver a major innovation to the global growth hormone deficiency (GHD) market with the company`s most advanced clinical candidate, somavaratan. Somavaratan is a novel, long-acting form of recombinant human growth hormone that is in global late-stage clinical trials to treat GHD in children and adults. Twice-monthly somavaratan is intended to reduce the burden of daily injection therapy by requiring significantly fewer injections, potentially improving compliance/adherence and treatment outcomes.
Dyax Corp. (Dyax) is a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of novel biotherapeutics for unmet medical needs, with an emphasis on inflammatory and oncology indications.
Lifemark Health Group is a diversified healthcare company in business since 1998 and has grown by acquisition over the past 13 years to include over 200 facilities across Canada.
Quality Assurance Management is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Carrollton, TX. To find more information about Quality Assurance Management, please visit www.qam.com
Antelope Valley Hospital, the only full-service, acute-care hospital in the Antelope Valley, has been delivering exceptional care to the community for more than 60 years. It offers the regions only trauma center, pediatric unit, NICU, inpatient mental health care, labor and delivery, Accredited Chest Pain Center/STEMI Receiving Center, Advanced Primary Stroke Center and Comprehensive Community Cancer Center.